These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
260 related items for PubMed ID: 8791962
1. High-dose ranitidine for the prevention of recurrent peptic ulcer disease in rheumatoid arthritis patients taking NSAIDs. ten Wolde S, Dijkmans BA, Janssen M, Hermans J, Lamers CB. Aliment Pharmacol Ther; 1996 Jun; 10(3):347-51. PubMed ID: 8791962 [Abstract] [Full Text] [Related]
2. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine. Ehsanullah RS, Page MC, Tildesley G, Wood JR. BMJ; 1988 Oct 22; 297(6655):1017-21. PubMed ID: 3142593 [Abstract] [Full Text] [Related]
3. The effect of ranitidine on NSAID related dyspeptic symptoms with and without peptic ulcer disease of patients with rheumatoid arthritis and osteoarthritis. Van Groenendael JH, Markusse HM, Dijkmans BA, Breedveld FC. Clin Rheumatol; 1996 Sep 22; 15(5):450-6. PubMed ID: 8894357 [Abstract] [Full Text] [Related]
4. Ranitidine in the treatment of non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers. Lancaster-Smith MJ, Jaderberg ME, Jackson DA. Gut; 1991 Mar 22; 32(3):252-5. PubMed ID: 2013419 [Abstract] [Full Text] [Related]
5. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs. Graham DY. Am J Med; 2001 Jan 08; 110(1A):58S-61S. PubMed ID: 11166000 [Abstract] [Full Text] [Related]
6. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients. Bianchi Porro G, Lazzaroni M, Petrillo M. Am J Gastroenterol; 1997 Apr 08; 92(4):663-7. PubMed ID: 9128319 [Abstract] [Full Text] [Related]
7. Progress in prophylaxis against nonsteroidal anti-inflammatory drug-associated ulcers and erosions. Omeprazole NSAID Steering Committee. Hawkey CJ. Am J Med; 1998 Mar 30; 104(3A):67S-74S; discussion 79S-80S. PubMed ID: 9572324 [Abstract] [Full Text] [Related]
8. New data on healing of nonsteroidal anti-inflammatory drug-associated ulcers and erosions. Omeprazole NSAID Steering Committee. Yeomans ND. Am J Med; 1998 Mar 30; 104(3A):56S-61S; discussion 79S-80S. PubMed ID: 9572322 [Abstract] [Full Text] [Related]
9. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy. Bianchi Porro G, Parente F, Imbesi V, Montrone F, Caruso I. Gut; 1996 Jul 30; 39(1):22-6. PubMed ID: 8881802 [Abstract] [Full Text] [Related]
10. [Ulcer healing with ranitidine and antacids despite continued therapy with non-steroidal anti-rheumatic drugs]. Stock KP, Bach GL. Z Rheumatol; 1988 Jul 30; 47(3):177-81. PubMed ID: 3213266 [Abstract] [Full Text] [Related]
11. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study. Raskin JB, White RH, Jaszewski R, Korsten MA, Schubert TT, Fort JG. Am J Gastroenterol; 1996 Feb 30; 91(2):223-7. PubMed ID: 8607484 [Abstract] [Full Text] [Related]
12. Critical effect of Helicobacter pylori infection on the effectiveness of omeprazole for prevention of gastric or duodenal ulcers among chronic NSAID users. Graham DY. Helicobacter; 2002 Feb 30; 7(1):1-8. PubMed ID: 11886469 [Abstract] [Full Text] [Related]
13. Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group. Agrawal NM, Campbell DR, Safdi MA, Lukasik NL, Huang B, Haber MM. Arch Intern Med; 2000 May 22; 160(10):1455-61. PubMed ID: 10826458 [Abstract] [Full Text] [Related]
14. Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine. Campbell DR, Haber MM, Sheldon E, Collis C, Lukasik N, Huang B, Goldstein JL. Am J Gastroenterol; 2002 Sep 22; 97(9):2208-14. PubMed ID: 12358234 [Abstract] [Full Text] [Related]
15. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. Taha AS, Hudson N, Hawkey CJ, Swannell AJ, Trye PN, Cottrell J, Mann SG, Simon TJ, Sturrock RD, Russell RI. N Engl J Med; 1996 May 30; 334(22):1435-9. PubMed ID: 8618582 [Abstract] [Full Text] [Related]
16. Neutrophils, Helicobacter pylori, and nonsteroidal anti-inflammatory drug ulcers. Taha AS, Dahill S, Morran C, Hudson N, Hawkey CJ, Lee FD, Sturrock RD, Russell RI. Gastroenterology; 1999 Feb 30; 116(2):254-8. PubMed ID: 9922304 [Abstract] [Full Text] [Related]
17. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis. Goldstein JL, Huang B, Amer F, Christopoulos NG. Clin Ther; 2004 Oct 30; 26(10):1637-43. PubMed ID: 15598480 [Abstract] [Full Text] [Related]
18. Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group. Peterson WL, Ciociola AA, Sykes DL, McSorley DJ, Webb DD. Aliment Pharmacol Ther; 1996 Jun 30; 10(3):251-61. PubMed ID: 8791947 [Abstract] [Full Text] [Related]
19. Effectiveness of ranitidine 150 mg at bedtime as maintenance therapy for healed gastric ulcers. Sue SO, Dawson DM, Brown JA, Wood DR, Kleoudis CS. Clin Ther; 1996 Jun 30; 18(6):1175-83. PubMed ID: 9001834 [Abstract] [Full Text] [Related]
20. Is ranitidine therapy sufficient for healing peptic ulcers associated with non-steroidal anti-inflammatory drug use? Yeomans ND, Svedberg LE, Naesdal J. Int J Clin Pract; 2006 Nov 30; 60(11):1401-7. PubMed ID: 17073837 [Abstract] [Full Text] [Related] Page: [Next] [New Search]